The development of autoimmune disease in the MRL/MpJ-Ipr inbred mouse strain depends upon the maturation of a subset of T lymphocytes that may cause sustained activation of immunological effector cells such as B cells and macrophages. We tested the hypothesis that abnormal effector cell activation reflects constitutive overexpression of a T cell cytokine. We found that a newly defined T cell cytokine, Eta-1, is expressed at very high levels in T cells from MRLA mice but not normal mouse strains and in a CD4 -8 -45R+ T cell clone. The Eta-1 gene encodes a secreted protein that binds specifically to macrophages, possibly via a cell adhesion receptor, resulting in alterations in the mobility and activation state of this cell type (Patarca, R ., G .
The MRL/MpJ-lpr (MRL/1) inbred mouse strain spontaneously develops a systemic autoimmune disease with histopathological features of human SLE and rheumatoid arthritis (1) . The development of this syndrome is associated with abnormal expansion of a subset of T cells that co-express CD1(Thy-1), TCRa/A and the B cell marker CD45R (B220 isoform of leukocyte common antigen) and lack both CD4 and CD8 surface antigens (CDI+CD45R+CD4 -CD8 -) (2) . The developmental pathway of this subset of T cells, termed double-negative (DN)t T cells, is poorly understood, although recent studies suggest that it may arise relatively late in ontogeny from CD4+ precursors (3) . Although the development of autoimmune disease is heralded by the appearance of large numbers of DN cells in peripheral lymphoid tissues, there is little information on the potential contribution of these cells to the sustained activation of immunological effector cells that may mediate the autoimmune process.
In the present studies we determined the level of cytokine genes expressed by a clone of DN T cells in vitro. We found Abbreviations used in this paper. DN, double-negative ; Eta-1, early T lymphocyte activation 1 .
1177 that these cells selectively and constitutively expressed high levels of the recently defined T cell cytokine Eta-1 (for early T lymphocyte activation 1) . This prompted an analysis of the expression of this gene during the development of autoimmune disease in the MRL/l model . We found that expression of this cytokine is substantially increased at the onset of the disease process and remains elevated throughout the course of this disorder. The relative contributions of MRL background genes and the lpr mutation to dysregulated expression of Eta-1 are defined, and the implications of these findings are discussed in the context of our current understanding of the immunological activities of the eta-1 protein.
Materials and Methods
Mice. MRLA and MRL/MpJ+ (MRL/n) mice were obtained from The Jackson Laboratory (Bar Harbor, ME) and from Dr. C. Reinisch (Tufts University School of Veterinary Medicine, Boston, MA) . Lymphoid tissues from C3H/HeJ-lpr (OH/1) and C57BL/6-lpr (B6/1) mice were kindly provided by Dr. H . C. Morse III (National Institutes of Health, Bethesda, MD). Age-matched C3H/HeJ (C3H/n) and C57BL/6J (B6/n) inbred mouse strains were obtained from The Jackson Laboratory.
Cell Lines and Immunofluorescence. Ar5 is a CD4' THl murine clone specific for arsonylated proteins (4) and Ar5v is a variant of this clone first detected because of its enhanced growth in vitro (5) . Cell surface immunofluorescenceWas performed by flow cytometric analysis using a FACS. Ar5 and Ar5v cells (>90% viability) were incubated with either anti-CD1(antiThy-1, AMT13, 1:100), anti-CD4 (1:25), anti-CD8 (1 :100) (Becton Dickinson & Co., Mountain View, CA), or anti-CD45R (anti-B220, RA3-2C2/1, 1 :20, from American Type Culture Collection, Rockville, MD) mAbs at 4°C for 40 min . Cells were then washed thrice with PBS and incubated with FITC-conjugated goat anti-rat IgG [F(ab')2 heavy and light chains, 1 :300; Cappel Laboratories, Durham, NC) for an additional 30 min before additional washing in PBS and analysis.
Slot Blot Analysis. Cellular RNA was extracted using the guanidium isothiocyanate method with cesium chloride gradient modification (6) . The amount of RNA in each sample was estimated by determining its absorbance at 260 nm (OD2w) . 20-Wg aliquots of RNA from each cellular sample (unless otherwise indicated) were blotted onto nitrocellulose filters using a Minifold II slot blotter (Schleicher & Schuell, Inc ., Keene, NH) and hybridized to 12P-labeled cDNA corresponding to Eta-1 (a 1.6-kb HaeIII fragment from pcD-Eta-1) (7), GAPDH (glyceraldehyde 3-phosphate dehydrogenase, a housekeeping gene) (8), 11,2 (9), 11,3 (10), and IFN-,y (5) . Northern blot analysis showed that the cDNA probes for Eta-1 and GAPDH hybridized to a single species of RNA and the levels of RNA quantitated by densitometric measurement of Northern blots were equivalent to those obtained by slot blot analysis . Quantitation was performed as described previously (7) and detailed below. After preflashing, Kodak X-OMAT films were exposed and the intensity of radioactivity ofthe autoradiograms was quantitated using an Ultroscan II laser densitometer (LKB Instruments, Inc., Gaithersburg, MD), adjusting exposure times so that the intensity of autoradiographic signals corresponded to the linear range of densitometric detection . To ensure that comparisons of Eta-1 RNA levels in different cellular samples were based upon the same amount of RNA in each sample, the area under the densitometric peak for Eta-1 for each cellular RNA sample was divided by the area under the GAPDH densitometric peak for the same cellular RNA sample. The ratios of Eta-1 RNA to GAPDH RNA for each cellular sample are referred to as relative densitometric units (RDU) .
Results
Expression ofEta-1 by a DN B220+ T Cell Clone. We examined a DN T cell clone that arose during the in vitro growth of a CD4+ THl clone, Ar5 (4, 5) . The variant, termed Ar5v, retained expression of CD1 but expressed neither CD4 nor CD8 . In addition, the variant clone but not the parent expressed CD45R according to immunofluorescence and thus had acquired the typical surface phenotype of DN cells ( Fig.   1 A) . Analysis of cDNA libraries derived from Ar5 and Ar5v also showed that the variant retained expression of the Ar5 TCR a//3 (not shown) .
We asked whether transition from the CD4+8-CD45R -phenotype of Ar5 to the CD4 -8 -CD45R' DN phenotype of Ar5v was accompanied by a change in the expression of genes encoding T cell cytokines. Resting Ar5 cells did not express detectable levels of rytokine genes, including IL2, 11,3, 11,4, and IFN--y or a newly defined T cell cytokine, Eta-1 (7, 11) (Fig. 1 B) . The Eta-1 gene encodes a secreted 1178 Eta-1 Expression in Murine Autoimmune Disease protein that binds specifically to macrophages, possibly via a cell adhesion receptor, resulting in alterations in the mobility and activation state of this cell type (7, 11) . In addition, recent studies have indicated that Eta-1 can enhance secretion of IgM and IgG by mixtures of macrophages and B cells (Patarca, R ., M . A . Lampe, M . V Iregai, and H . Cantor, manuscript in preparation) . The DN variant Ar5v cells constitutively expressed high levels of Eta-1 RNA and showed a less pronounced but significant elevation in expression of IFN-, y RNA (Fig. 1 B) . Enhanced constitutive expression of other TH1 cytokines, including 11,2 and IL3, was not detected, nor was there evidence for aberrant expression of the TI-12-associated rytokine, 11,4 (Fig. 1 B) .
Expression of Eta-1 by DN T Cells In Viva We asked whether the expanded population of DN cells in peripheral lymphoid tissues of MRLA mice also showed evidence of dysregulated Eta-1 expression . Lymphadenopathy in MRL/1 mice secondary to expansion of DN cells begins at ti3 mo of age and reaches maximum levels by 5-6 mo of age (12).
Elevated levels of Eta-1 RNA were detected in thymus, lymph nodes (LN), and spleen from the MRL/1 mouse strain at 5 .5 mo of age but not in lymphoid tissue of age-matched MRL/n controls, which lack the lpr mutation and do not exhibit signs of autoimmune disease at this time (Fig. 2) . The Eta-1 RNA expressed by LN cells from MRL/l mice, and by Ar5v cells, was indistinguishable from that found in activated T cells from normal mice, as judged from Northern blot and S1 nuclease protection analysis (not shown) . We determined the time course of elevated Eta-1 expression in the thymus and LN of MRL/l and MRL/n mice to assess its relationship to the development ofautoimmune disease. Eta-1 RNA levels increased in thymus slightly before LN at 2 .5-3 mo of age and reached maximum levels by 4.5-5 mo of age (Fig. 3 A) .
In contrast, Eta-1 RNA levels were not significantly increased in LN of control MRL/n mice during this time (Fig. 3 A) .
These kinetics o£ enhanced Eta-1 expression paralleled the development of overt autoimmune disease, which begins at -3 .5 mo of age and results in 50% mortality by 5-5 .5 mo of age (1, 12) . The increase in Eta-1 expression compared with levels of a housekeeping gene, GAPDH, over the period from 2.5 to 4 .5 mo after birth, was -25-fold (Fig . 3 A) . However, the absolute increase in Eta-1 expression in LN tissues was substantially higher because of the development of severe lymphadenopathy during this time : total levels of Eta-1 RNA in peripheral LN of MRL/I mice increased by N4 orders of magnitude (Fig. 3 B) .
CD1' DN cells comprise >90% of the cells of LN from MRL/l mice (2) and therefore were likely to account for the bulk of elevated Eta-1 RNA levels. To define the contribution of this subset to enhanced Eta-1 expression, RNA was extracted from separated DN cells and from CD4' or CD8' T cells in LN . The DN population contained almost all of the Eta-1 RNA expressed by unseparated lymph node cells (Fig. 4) .
Comparison of Eta-1 Gene Expression to Expression of Other Northern blot analysis showed that the probes used for the Eta-1 gene hybridized to a single species of RNA and that the size of the Eta-1 RNA transcript in Ar5v cells was the same as that in Ar5 cells . Sl nuclease protection analysis using the 5'-labeled 1 kb BstXI-Sspl fragment from the Eta-1 cDNA insert in pcD-Etal (7) confirmed the identity of both transcripts at the nucleotide sequence level (not shown) .
Figure 2. Eta-1 gene expression in lymphoid tissues of MRL/l and MRL/n mice. Thymus, spleen, and mesenteric LN were obtained from 5-mo-old MRLA mice (which display marked lymphoid hyperplasia and activated macrophages) and 6-mo-old congenic MRL/n mice that had been housed in the same colony after their arrival from The Jackson Laboratory. 1, 3 .5, and 7 hg of total RNA were subjected to slot blot analysis using a 32P-labeled murine Eta-1 cDNA probe as described in Materials and Methods. Figure 3 . (A) Time course of Eta-1 RNA expression in LN and thymus cells of MRL/l and MRL/n mice. Cellular RNA was extracted from LN (") and thymus (") from cohorts of MRLA and MRL/n mice at the ages indicated on the abscissa. The ratio of Eta-1 RNA levels to GAPDHlevels of RNA from each cellular sample, as measured by densitometric anal ysis, is shown on the ordinate and expressed as relative densitometric units (RDU) (see Materials and Methods for details) . The points indicated in the graph correspond to the mean of at least three different samples; standard deviation of each mean value is <20% . The intensity of the autoradiographic signals obtained after blotting RNA from heart, muscle, or adrenal gland with this Eta-1 cDNA probe did not exceed the background signal of the film. (B) Total Eta-1 activity in LN from MRL/l mice. The levels of Eta-1 RNA expressed as relative densitometric units (Eta-1/GAPDH) as described for A are multiplied by the ratio of LN weight at the age indicated to LN weight at 1 mo of age. LN Eta-1 activity is depicted on a logto scale. The hatched horizontal bar indicates the interval from the initial signs of autoimmune disease to the age corresponding to 50% mortality from the disease process. 1180 significant elevation of IFN-y (Fig. 1) . We asked whether this was also the case for the expanded population of DN cells in the LN of MRL/l mice, or whether these cells exhibited a more generalized dysregulation of lymphokine gene expression . We found that the levels of IL2, IL3, and IL4
RNA were not significantly elevated in MRL/l mice compared with age-matched MRL/n controls, in contrast to the striking -elevation of Eta-1 RNA levels ( Fig. 5 ; Table 1 ). As was the case for the DN Ar5v clone, IFN-y RNA levels were significantly elevated in LN from MRL/1 mice . Increased expression of this cytokine was transient and was not evident until relatively late in the disease process (4.5-5 .5 mo) . Moreover, the degree of elevation at this time was considerably less than noted for Eta-1 ( Fig. 5 ; Table 1 ) .
We studied expression of Eta-1 in nonlymphoid tissues of MRL/l mice. Eta-1 was not significantly elevated in muscle, heart or adrenal tissue (not shown) . However, substantial levels of Eta-1 RNA were found in lung, consistent with the development of peribronchial lymphocytic infiltration and pneumonitis associated with MRL/1 disease (1) . Analysis of TCRa levels in pulmonary tissue as a genetic marker of infiltrating T cells showed that increased levels of TCR a RNA correlated closely with elevation in Eta-1 expression in lung tissue (Fig. 6) .
Genetic Control of Eta-1 Expression in MRL/1 Mice. The above comparisons of Eta-1 RNA expression in MRLA and Figure 4 . Eta-1 RNAlevels in LN cells and in DN subpopulations of T cells. RNA was extracted from either total lymph node cell suspension or from the adherent lg* (CD4*8+) and nonadherent lg -(CD4 -8 -) subpopulations obtained after panning LN cells with anti-CD4 and anti-CD8 antibody as described previously (24) . Immuno$uores cent analysis of the separated subpopulations indicated that the nonadherent cells contained <1% CD4*, CD8+, or Ig* cells while contamination of the CD4*8* cells with DN cells was 10-15% .
Eta-1 Expression in Murine Autoimmune Disease MRL/n mice suggest that the lpr gene is necessary for elevated expression of this gene in peripheral lymphoid cells. However, they did not distinguish between the following possibilities: (a) the lpr gene is necessary and sufficient for elevated Eta-1 expression or (b) the lpr gene and the associated MRL background gene(s) are both necessary for maximal expression of Eta-1 . The lpr mutation has been bred onto several normal inbred strains, including C57BL/6J (B6/n) and C3H/HeJ (C3H/n) (2) . This results in the development of lymphadenopathy and formation of high levels of IgG autoantibodies. However, the C3H/l and B6/1 strains do not develop the severe manifestations of autoimmune disease that characterize MRL/l mice (2) . Comparison of Eta-1 RNA levels in enlarged LN from B6/1, C3H/1, and MRL/l mice showed that although the lpr gene was sufficient for elevation of Eta-1 RNA levels, MRL background genes (derived from five inbred strains : C57BL/6J, C3H/HeJ, LG, AKR, A/J) were required for maximal levels of expression (Fig. 7) . The Ipr mutation is not likely to map to the Eta-1 locus since its presence does not alter the restriction fragment length polymorphic patterns of the Eta-1 gene in a panel of inbred mouse strains (data not shown) . RNA samples from LN of MRLA and MRL/n were analyzed by slot blots, and levels of gene expression for each cytokine are expressed as relative densitometric units (RDU) as described in Materials and Methods. Exposure times for autoradiograms were adjusted so that the intensity of the autoradiographic signals associated with CAPDH was equivalent for MRLA and MRL/n RNA samples.
Discussion
The data presented in this report shed new light on the role of abnormal T cell development in autoimmune disease in MRLA mice. DN cells that are abnormally expanded in these mice constitutively express extremely high levels of Eta-1 and the time course of enhanced expression is closely associated with the onset and development of autcimmune disease. Eta-1 expression is also elevated in association with abnormal expansion of DN cells in the C3H/l and B6/1 mouse strains. However, increased Eta-1 expression in these two strains is intermediate between normal inbred strains and the MRL/l strain . This finding is consistent with the milder form of autoimmune disease displayed by B6/1 and C3H/1, which develop anti-DNA antibodies and rheumatoid factor but do not develop severe immune complex glomerulonephritis (1, 2) .
Several explanations have been put forward to explain the role of abnormal T cell differentiation in the development of autoimmune disease in the MRLA model. One involves a differentiative defect that results in failure to delete autoreactive T cell clones when they arise in the thymus. However, several recent studies have failed to detect such abnormalities (13, 14) . A second holds that the DN subset constitutively expresses elevated levels of cytokines, resulting in chronic activation of immunologic effector cells such as macrophages and B cells (15) . The studies reported here are consistent with (16) and expression of the proto-oncogene c-myb (17) . The availability of the DN Ar5v cell line may allow analysis in vitro of the molecular basis of this potential alternative activation pathway.
Elevated levels of IFN-y in MRLA mice have been reported previously, although the degree of this elevation and its temporal pattern were not determined (18, 19) . We find that the degree of elevation is relatively small compared with Eta-1 and occurs late and transiently in the course of disease. We did not detect enhanced levels of 11,2, 11,3, or IIJ4 RNA, which represent cytokines normally associated with T cell inducer activity. Both Eta-1 and IFN-y can bind to and acti- Figure 7 . Maximum levels of Eta-1 in LN cells from MRLA, C3H/1, and B6/1 . Peripheral (axillary, brachial, femoral) and mesenteric lymph nodes were obtained from the indicated mouse strains at 3-mo intervals.
Maximum levels of Eta-1 expression shown in the graph were observed at 4.5 mo for MRLA mice, and at 7 mo for C3H/l and B6/1 mice. Cellular RNA was extracted and analyzed as described in Materials and
Methods. The height of the bars corresponds to mean relative densitometric units. Standard errors were <20% of mean . vate macrophages (7, 11) , consistent with evidence that MRL/l mice harbor activated macrophages that may mediate tissue destruction (20) and indirectly contribute to enhanced Ig production by B cells. Although the findings reported here do not directly implicate Eta-1 in the pathogenesis of this murine model of lupus, they indicate that elevated Eta-1 expression may represent a highly specific genetic marker for the T cell developmental defect associated with this type of autoimmune disease. The appearance of elevated levels of Eta-1 gene expression in the thymus before the appearance of substantial levels of DN T cells in the periphery and the dramatic and relatively selective increase of Eta-1 gene expression in DN T cells during the disease process suggest that this cytokine may also contribute to the pathogenesis of this
